/Companies

ImmunoRx Pharma

Wilmington, US · Founded 2020 · Delaware corporation · 1 known investors

Find your way into ImmunoRx Pharma

Sign up to see every warm intro you have to ImmunoRx Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmunoRx Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

CF
Caroline FortierNamed on SEC filing
MC
Mark CiprianoNamed on SEC filing
MR
Marc RiviereNamed on SEC filing
PT
Philippe TessierNamed on SEC filing
AL
Alexandre LebeautNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2.7M disclosed across 1 round · 2020

▶$2.7MraisedFeb 2021 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Caroline FortierExecutive Officer
  • Mark CiprianoExecutive Officer
  • Marc RiviereDirector
  • Philippe TessierDirector
  • Alexandre LebeautDirector
Offering amount
$25.4M
Amount sold
$2.7M
Proceeds to insiders
$86K
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are ImmunoRx Pharma's investors?
ImmunoRx Pharma's investors include TVM Life Science Innovation SCSp.
How much funding has ImmunoRx Pharma raised?
ImmunoRx Pharma has disclosed $2.7M raised across 1 round.
Where is ImmunoRx Pharma headquartered?
ImmunoRx Pharma is headquartered in Wilmington, US.